Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.74866675
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, ...

254.19 -1.43 (-0.56%)

36.62% Gain from 52W Low

106.9K

XNAS Volume

XNAS 11 Aug, 2026 12:33 PM (EDT)

Not Eligible

Expensive Valuation

20.2 / 100

Technically Neutral

49.8 / 100

309

1Yr Price target upside is 22%

18 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..